89R13770 MPF-D
 
  By: Simmons H.B. No. 3554
 
 
 
A BILL TO BE ENTITLED
 
AN ACT
  relating to establishment of the Texas Rare Disease Advisory
  Council.
         BE IT ENACTED BY THE LEGISLATURE OF THE STATE OF TEXAS:
         SECTION 1.  Subtitle E, Title 2, Health and Safety Code, is
  amended by adding Chapter 101A to read as follows:
  CHAPTER 101A. TEXAS RARE DISEASE ADVISORY COUNCIL
         Sec. 101A.001.  DEFINITIONS. In this chapter:
               (1)  "Advisory council" means the Texas Rare Disease
  Advisory Council established under this chapter.
               (2)  "Rare disease" means a disease, disorder, or
  condition that affects fewer than 200,000 individuals in the United
  States.
         Sec. 101A.002.  ESTABLISHMENT. (a) The Texas Rare Disease
  Advisory Council is established to advise the governor, state
  agencies, and private entities that provide health care services or
  other treatment to individuals diagnosed with rare diseases in this
  state on strategies for improving health outcomes for those
  individuals.
         (b)  The department shall provide to the advisory council
  resources, personnel, and other administrative support as
  necessary for the council to carry out its duties under this
  chapter.
         Sec. 101A.003.  ADVISORY COUNCIL MEMBERS. (a) The advisory
  council is composed of 23 members appointed as follows:
               (1)  11 members appointed by the governor as follows:
                     (A)  one representative of the department;
                     (B)  one representative of the commission;
                     (C)  one representative of the Texas Department of
  Insurance;
                     (D)  one representative of the Texas Education
  Agency;
                     (E)  one geneticist practicing in this state;
                     (F)  one registered nurse or advanced practice
  registered nurse licensed and practicing in this state with
  experience in treating rare diseases;
                     (G)  one hospital administrator of a hospital in
  this state that provides care to individuals diagnosed with a rare
  disease;
                     (H)  one pharmacist licensed and practicing in
  this state with experience dispensing prescription drugs used in
  treating rare diseases;
                     (I)  one representative of the biotechnology
  industry;
                     (J)  one representative of a health insurance
  company; and
                     (K)  one physician licensed and practicing in this
  state with experience in treating rare diseases;
               (2)  six members appointed by the lieutenant governor
  as follows:
                     (A)  one representative of an academic research
  institution in this state that receives grant funding for rare
  disease research;
                     (B)  one physician licensed and practicing in this
  state with experience in treating rare diseases;
                     (C)  one individual who is 18 years of age or older
  and who is diagnosed with a rare disease;
                     (D)  two individuals who are, or previously served
  as, caregivers for an individual diagnosed with a rare disease; and
                     (E)  one representative of an organization that
  provides care or other support to individuals diagnosed with a rare
  disease in this state; and
               (3)  six members appointed by the speaker of the house
  of representatives as follows:
                     (A)  one representative of an academic research
  institution in this state that receives grant funding for rare
  disease research;
                     (B)  one physician licensed and practicing in this
  state with experience in treating rare diseases;
                     (C)  one individual who is 18 years of age or older
  and who is diagnosed with a rare disease;
                     (D)  two individuals who are, or previously served
  as, caregivers for an individual diagnosed with a rare disease; and
                     (E)  one representative of an organization that
  provides care or other support to individuals diagnosed with a rare
  disease in this state.
         (b)  Advisory council members serve staggered four-year
  terms, with the terms of one-half of the members, or as near to
  one-half as possible, expiring February 1 of each odd-numbered
  year.
         (c)  A vacancy on the advisory council shall be filled for
  the unexpired term in the same manner as the original appointment.
         Sec. 101A.004.  PRESIDING OFFICER; ASSISTANT PRESIDING
  OFFICER. The governor shall annually select from among the
  advisory council members a presiding officer and an assistant
  presiding officer.
         Sec. 101A.005.  COUNCIL MEETINGS. (a) The advisory council
  shall meet:
               (1)  at the call of the advisory council's presiding
  officer; and
               (2)  on request by a majority of the advisory council
  members.
         (b)  A majority of the voting members of the advisory council
  constitutes a quorum.
         (c)  A meeting conducted under this section may be in person
  or by video conference call, as determined by the advisory
  council's presiding officer.
         (d)  The advisory council shall provide notice of upcoming
  advisory council meetings on the department's Internet website.
         Sec. 101A.006.  DUTIES. (a) The advisory council shall:
               (1)  consult with experts on rare diseases and solicit
  public comment to develop policy recommendations for improving the
  treatment of rare diseases in this state;
               (2)  develop strategy recommendations for academic
  research institutions of higher education in this state to
  facilitate continued research on rare diseases;
               (3)  develop strategy recommendations for health care
  providers to better recognize and diagnose rare diseases to improve
  patient treatment; and
               (4)  make recommendations to the department and other
  state agencies on matters affecting individuals diagnosed with a
  rare disease, including emergency preparedness and response
  resources for a pandemic or natural disaster.
         (b)  The advisory council shall provide the department with
  the strategy recommendations developed under Subsection (a)(3) for
  publication on the department's Internet website.
         Sec. 101A.007.  ANNUAL REPORT. (a) Not later than September
  1 of each year, the advisory council shall prepare and submit to the
  governor and commissioner a report that includes:
               (1)  a summary of the advisory council's activities for
  the preceding year; and
               (2)  recommendations for legislative or other action on
  rare disease research and care.
         (b)  The advisory council shall publish the report prepared
  and submitted under Subsection (a) on the department's Internet
  website.
         Sec. 101A.008.  APPLICABILITY OF OTHER LAW. Section
  2110.008, Government Code, does not apply to the advisory council.
         SECTION 2.  Not later than December 1, 2025, the appropriate
  appointing authority shall appoint the initial members to the Texas
  Rare Disease Advisory Council as required by Section 101A.003(a),
  Health and Safety Code, as added by this Act, with the initial
  members' terms expiring as follows:
               (1)  the terms of five members appointed under Section
  101A.003(a)(1), of three members appointed under Section
  101A.003(a)(2), and of three members appointed under Section
  101A.003(a)(3) expiring February 1, 2029; and
               (2)  the terms of six members appointed under Section
  101A.003(a)(1), of three members appointed under Section
  101A.003(a)(2), and of three members appointed under Section
  101A.003(a)(3) expiring February 1, 2031.
         SECTION 3.  Notwithstanding Section 101A.005, Health and
  Safety Code, as added by this Act, the Texas Rare Disease Advisory
  Council shall conduct the council's first meeting not later than
  January 1, 2026.
         SECTION 4.  Notwithstanding Section 101A.007, Health and
  Safety Code, as added by this Act, the Texas Rare Disease Advisory
  Council shall submit the first report required by that section not
  later than September 1, 2026.
         SECTION 5.  This Act takes effect September 1, 2025.